Supporting Precision Dosing in Drug Labeling

Affiliations

¹ Children's Hospital Los Angeles and the University of Southern California, Los Angeles, California, USA.
² Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
³ Departments of Pharmacy and Pharmacology, Pharmacometrics Center of Excellence, Colleges of Pharmacy and Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
⁴ Northwestern Memorial Hospital, Chicago, Illinois, USA.
⁵ Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
⁶ Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA.
⁷ Department of Clinical Pharmacy, School of Pharmacy, University of California - San Francisco, San Francisco, California, USA.
⁸ Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Review

Michael Neely et al. Clin Pharmacol Ther. 2021 Jan.

. 2021 Jan;109(1):37-41.

doi: 10.1002/cpt.2054. Epub 2020 Oct 27.

¹ Children's Hospital Los Angeles and the University of Southern California, Los Angeles, California, USA.
² Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
³ Departments of Pharmacy and Pharmacology, Pharmacometrics Center of Excellence, Colleges of Pharmacy and Graduate Studies, Midwestern University, Downers Grove, Illinois, USA.
⁴ Northwestern Memorial Hospital, Chicago, Illinois, USA.
⁵ Antiviral Pharmacology Laboratory, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
⁶ Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA.
⁷ Department of Clinical Pharmacy, School of Pharmacy, University of California - San Francisco, San Francisco, California, USA.
⁸ Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

No abstract available

References

1. Hoon, D. et al. Trends in off-label drug use in ambulatory settings: 2006-2015. Pediatrics 144, e20190896 (2019).
1. Tansarli, G.S., Rafailidis, P.I., Kapaskelis, A. & Falagas, M.E. Frequency of the off-label use of antibiotics in clinical practice: a systematic review. Expert Rev. Anti. Infect. Ther. 10, 1383-1392 (2012).
1. Neely, M. Scalpels not hammers: the way forward for precision drug prescription. Clin. Pharmacol. Ther. 101, 368-372 (2017).
1. Reisinger, T.L., Newman, M., Loring, D.W., Pennell, P.B. & Meador, K.J. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav. 29, 13-18 (2013).
1. Rybak, M.J. et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am. J. Health-Syst. Pharm. 77, 835-864 (2020).